Familial moyamoya disease associated with graves' disease in a mother and daughter

Neurologia Medico-Chirurgica

Volumn 50, Issue 8, 2010, Pages 668-674

  Tokimura, Hiroshi ^a   Tajitsu, Kenichiro ^b   Takashima, Hiroshi ^a   Hirayama, Takahisa ^b   Tsuchiya, Masahiro ^a   Takayama, Kenji ^c   Arita, Kazunori ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Sendai Shimin Hospital   (Japan)

^c Sendai Neurosurgical Clinic   (Japan)

Author keywords

Cerebral infarction; Genetic factor; Graves' disease; Hyperthyroidism; Moyamoya disease

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ADULT; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN ARTERY BYPASS; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN INFARCTION; CAROTID ARTERIOGRAPHY; CASE REPORT; CEREBRAL REVASCULARIZATION; DYSESTHESIA; EXOPHTHALMOS; FAMILIAL DISEASE; FAMILY HISTORY; FEMALE; GRAVES DISEASE; HAND PARESTHESIA; HEMIANOPIA; HEMIPARESIS; HUMAN; HYPERHIDROSIS; HYPERLIPIDEMIA; HYPERTENSION; HYPERTHYROIDISM; HYPOTHYROIDISM; INTERNAL CAROTID ARTERY OCCLUSION; MAGNETIC RESONANCE ANGIOGRAPHY; MOYAMOYA DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; TACHYCARDIA; THYROID TUMOR; THYROIDECTOMY; THYROTOXICOSIS;

CEREBRAL ANGIOGRAPHY; CEREBRAL INFARCTION; CEREBRAL REVASCULARIZATION; FEMALE; GRAVES DISEASE; HUMANS; INTRACRANIAL HEMORRHAGES; MIDDLE AGED; MOYAMOYA DISEASE; PEDIGREE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77956195347     PISSN: 04708105     EISSN: 13498029     Source Type: Journal    
DOI: 10.2176/nmc.50.668     Document Type: Article

References (29)

1. Akamizu T, Nakamura Y, Tamaoki A, Inaba Y, Amino N, Seino Y: Prevalence and clinico-epidemiology of familial Graves' disease in Japan based on nationwide epidemiologic survey in 2001. Endocr J 50: 429-436, 2003
2. Boerkoel CF, Nowaczyk MJM, Blaser SI, Meschino WS, Weksberg R: Schimke immuno-osseous dysplasia complicated by moyamoya phenomenon. Am J Med Genet 78: 118-122, 1998
3. Boerkoel CF, Takashima H, John J, Yan J, Stankiewicz P, Rosenbarker L, Andre JL, Bogdanovic R, Burguet A, Cockfield S, Cordeiro I, Frund S, Illies F, Joseph M, Kaitila I, Lama G, Loirat C, McLeod DR, Milford DV, Petty EM, Rodrigo F, Saraiva JM, Schmidt B, Smith GC, Spranger J, Stein A, Thiele H, Tizard J, Weksberg R, Lupski JR, Stockton DW: Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia. Nature Genet 30: 215-220, 2002
4. Cramer SC, Robertson RL, Dooling EC, Scott RM: Moyamoya and Down syndrome. Clinical and radiological features. Stroke 27: 2131-2135, 1996
5. Fukui M: Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 99 Suppl 2: S238-240, 1997
6. Golomb MR, Biller J, Smith JL, Edwards-Brown M, Sanchez JC, Nebesio TD, Garg BP: A 10-year-old girl with coexistent moyamoya disease and Graves' disease. J Child Neurol 20: 620-624, 2005
7. Guo DC, Papke CL, Tran-Fadulu V, Regalado ES, Avidan N, Johnson RJ, Kim DH, Pannu H, Willing MC, Sparks E, Pyeritz RE, Singh MN, Dalman RL, Grotta JC, Marian AJ, Boerwinkle EA, Frazier LQ, LeMaire SA, Coselli JS, Estrera AL, Safi HJ, Veeraraghavan S, Muzny DM, Wheeler DA, Willerson JT, Yu RK, Shete SS, Scherer SE, Raman CS, Buja LM, Milewicz DM: Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and moyamoya disease, along with thoracic aortic disease. Am J Hum Genet 84: 617-627, 2009
8. Hsu SW, Chaloupka JC, Fattal D: Rapidly progressive fatal bihemispheric infarction secondary to moyamoya syndrome in association with Graves thyrotoxicosis. AJNR Am J Neuroradiol 27: 643-647, 2006
9. Ikeda H, Sasaki T, Yoshimoto T, Fukui M, Arinami T:Mapping of familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet 64: 533-537, 1999
10. Im SH, Oh CW, Kwon OK, Kim JE, Han DH: Moyamoya disease associated with Graves disease: Special considerations regarding clinical significance and management. J Neurosurg 102: 1013-1017, 2005
11. Jacobson EM, Tomer Y: The genetic basis of thyroid autoimmunity. Thyroid 17: 949-961, 2007
12. Kim JY, Kim BS, Kang KJ: Dilated cardiomyopathy in thyrotoxicosis and moyamoya disease. Int J Cardiol 80: 101-103, 2001
13. Kushima K, Satoh Y, Ban Y, Taniyama M, Ito K, Sugita K: Graves' thyrotoxicosis and moyamoya disease. Can J Neurol Sci 18: 140-142, 1991
14. Leno C, Mateo I, Cid C, Berciano J, Sedano C: Autoimmunity in Down's syndrome: Another possible mechanism of moyamoya disease. Stroke 29: 868-869, 1998
15. Liu JS, Juo SH, Chen WH, Chang YY, Chen SS: A case of Graves' diseases associated with intracranial moyamoya vessels and tubular stenosis of extracranial internal carotid arteries. J Formos Med Assoc 93: 806-809, 1994
16. Maki Y, Enomoto T: Moyamoya disease. Childs Nerv Syst 4: 203-212, 1988
17. Matsumoto K, Nogaki H, Yamamoto K, Sasabe F, Morimatsu M: [A case of moyamoya disease complicated with Basedow disease]. No Socchu 14: 409-413, 1992 (Japanese)
18. Mineharu Y, Liu W, Inoue K, Matsuura N, Inoue S, Takenaka K, Ikeda H, Houkin K, Takagi Y, Kikuta K, Nozaki K, Hashimoto N, Koizumi A: Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology 70: 2357-2363, 2008
19. Nakamura K, Yanaka K, Ihara S, Nose T: Multiple intracranial arterial stenoses around the circle of Willis in association with Graves' disease: Report of two cases. Neurosurgery 53: 1210-1214, 2003
20. Sakai K, Shirasawa S, Ishikawa N, Ito K, Tamai H, Kuma K, Akamizu T, Tanimura M, Furugaki K, Yamamoto K, Sasazuki T: Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese. Hum Mol Genet 10: 1379-1386, 2001
21. Sakurai K, Horiuchi Y, Ikeda H, Ikezaki K, Yoshimoto T, Fukui M, Arinami T: A novel susceptibility locus for moyamoya disease on chromosome 8q23. J Hum Genet 49: 278-281, 2004
22. Sasaki T, Nogawa S, Amano T: Co-morbidity of moyamoya disease with Graves' disease. Report of three cases and a review of the literature. Intern Med 45: 649-653, 2006
23. Shen AL, Shan-Jin R, Shinn-Kuang L: Concurrent moyamoya disease and Graves' thyrotoxicosis: Case report and literature review. Acta Neurol Taiwan 15: 114-119, 2006
24. Sokoloff L, Wechsler RL, Mangold R, Balls K, Kety SS: Cerebral blood flow and oxygen consumption in hyperthyroidism before and after treatment. J Clin Invest 32: 202-208, 1953
25. Suzuki J, Takaku A: Cerebrovascular ''Moyamoya'' disease showing abnormal net-like vessels in base of brain. Arch Neurol 20: 288-299, 1969
26. Tendler BE, Shoukri K, Malchoff C, MacGillivray D, Duckrow R, Talmadge T, Ramsby G: Concurrence of Graves' disease and dysplastic cerebral blood vessels of the moyamoya variety. Thyroid 7: 625-629, 1997
27. Utku U, Asil T, Celik Y, Tucer D: Reversible MR angiographic findings in a patient with autoimmune Graves disease. AJNR Am J Neuroradiol 25: 1541-1543, 2004
28. Wakai K, Tamakoshi A, Ikezaki K, Fukui M, Kawamura T, Aoki R, Kojima M, Lin Y, Ohno Y: Epidemiological features of moyamoya disease in Japan: Findings from a nationwide survey. Clin Neurol Neurosurg 99 Suppl 2: S1-5, 1997
29. Wakamoto H, Ishiyama N, Miyazaki H, Shinoda A, Tomita H: [The stenoses at the terminal portion of the internal carotid artery improved after initiation of antithyroid therapy: A case report]. No Shinkei Geka 28: 379-383, 2000 (Japanese)